ยินดีต้อนรับกลับมา
เข้าร่วม CoinTime
เข้าสู่ระบบ email
สร้างบัญชี email
ตรวจสอบกล่องจดหมายของคุณ
Ocular Therapeutix
About
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
- 51 - 100
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $15M
- Industries
- Biotechnology,Health Care,Medical Device
- Founded date
- Jan 1, 2006
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Ocular Therapeutix, Inc. engages in the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. Its products include ReSure Adherent Ocular Bandage, a synthetic ocular bandage for ophthalmic surgery; ReSure Sealant, a synthetic and biocompatible hydrogel that creates a temporary, soft, and lubricious surface barrier to protect clear corneal incisions in the immediate post-operative period; and prostaglandin analog punctum plugs that are hydrogel-based punctum plug depots to deliver prostaglandin analogs to treat glaucoma.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 10, 2013 | Series D | $23.80M | 1 | — | — | Detail |
| Feb 3, 2011 | Series D | $14M | 1 | — | — | Detail |
| Jan 12, 2011 | Series C | $6M | 1 | — | — | Detail |
| Jun 24, 2009 | Series C | $15M | 1 | — | — | Detail |
| Mar 7, 2008 | Series B | $6M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
— | Series D |
